These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 32951085)

  • 21. Potential anticancer agent for selective damage to mitochondria or lysosomes: Naphthalimide-modified fluorescent biomarker half-sandwich iridium (III) and ruthenium (II) complexes.
    Ma W; Zhang S; Tian Z; Xu Z; Zhang Y; Xia X; Chen X; Liu Z
    Eur J Med Chem; 2019 Nov; 181():111599. PubMed ID: 31408807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis, characterization, and DNA-binding studies of ruthenium complexes [Ru(tpy)(ptn)]2+ and Ru(dmtpy)(ptn)]2+.
    Li LY; Jia HN; Yu HJ; Du KJ; Lin QT; Qiu KQ; Chao H; Ji LN
    J Inorg Biochem; 2012 Aug; 113():31-9. PubMed ID: 22687492
    [TBL] [Abstract][Full Text] [Related]  

  • 23. On the antitumor properties of novel cyclometalated benzimidazole Ru(II), Ir(III) and Rh(III) complexes.
    Yellol GS; Donaire A; Yellol JG; Vasylyeva V; Janiak C; Ruiz J
    Chem Commun (Camb); 2013 Dec; 49(98):11533-5. PubMed ID: 24177492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Half sandwich Ru(ii)-acylthiourea complexes: DNA/HSA-binding, anti-migration and cell death in a human breast tumor cell line.
    Colina-Vegas L; Luna-Dulcey L; Plutín AM; Castellano EE; Cominetti MR; Batista AA
    Dalton Trans; 2017 Oct; 46(38):12865-12875. PubMed ID: 28920989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spectroscopic and biological approach in the characterization of a novel 14-membered [N4] macrocyclic ligand and its palladium(II), platinum(II), ruthenium(III) and iridium(III) complexes.
    Rani S; Kumar S; Chandra S
    Spectrochim Acta A Mol Biomol Spectrosc; 2014 Jan; 118():244-50. PubMed ID: 24051297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, characterization; DNA binding and antitumor activity of ruthenium(II) polypyridyl complexes.
    Srishailam A; Gabra NM; Kumar YP; Reddy KL; Devi CS; Anil Kumar D; Singh SS; Satyanarayana S
    J Photochem Photobiol B; 2014 Dec; 141():47-58. PubMed ID: 25318017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of PPh₃ moiety in the anticancer activity of new organometallic ruthenium complexes.
    Sáez R; Lorenzo J; Prieto MJ; Font-Bardia M; Calvet T; Omeñaca N; Vilaseca M; Moreno V
    J Inorg Biochem; 2014 Jul; 136():1-12. PubMed ID: 24690555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA interaction, antimicrobial, anticancer activities and molecular docking study of some new VO(II), Cr(III), Mn(II) and Ni(II) mononuclear chelates encompassing quaridentate imine ligand.
    Abdel-Rahman LH; Abu-Dief AM; Aboelez MO; Hassan Abdel-Mawgoud AA
    J Photochem Photobiol B; 2017 May; 170():271-285. PubMed ID: 28456118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multinuclear Ru(ii) and Ir(iii) decorated tetraphenylporphyrins as efficient PDT agents.
    Cabrera-González J; Soriano J; Conway-Kenny R; Wang J; Lu Y; Zhao J; Nogués C; Draper SM
    Biomater Sci; 2019 Aug; 7(8):3287-3296. PubMed ID: 31187805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective Coordination Mode of Acylthiourea Ligands in Half-Sandwich Ru(II) Complexes and Their Cytotoxic Evaluation.
    Cunha BN; Luna-Dulcey L; Plutin AM; Silveira RG; Honorato J; Cairo RR; de Oliveira TD; Cominetti MR; Castellano EE; Batista AA
    Inorg Chem; 2020 Apr; 59(7):5072-5085. PubMed ID: 32208661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences in Stability, Cytotoxicity, and Mechanism of Action of Ru(II) and Pt(II) Complexes of a Bidentate N,O Donor Ligand.
    Maji M; Acharya S; Maji S; Purkait K; Gupta A; Mukherjee A
    Inorg Chem; 2020 Jul; 59(14):10262-10274. PubMed ID: 32585099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Unexpected DNA binding properties with correlated downstream biological applications in mono vs. bis-1,8-naphthalimide Ru(II)-polypyridyl conjugates.
    Ryan GJ; Poynton FE; Elmes RB; Erby M; Williams DC; Quinn SJ; Gunnlaugsson T
    Dalton Trans; 2015 Oct; 44(37):16332-44. PubMed ID: 26305507
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ru(II) Polypyridyl Complexes Derived from Tetradentate Ancillary Ligands for Effective Photocaging.
    Li A; Turro C; Kodanko JJ
    Acc Chem Res; 2018 Jun; 51(6):1415-1421. PubMed ID: 29870227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNA Binding Behavior, Sensor Studies, Antimicrobial, Photocleavage and In vitro Cytotoxicity of Synthesized Ru(II) Complexes with Assorted Intercalating Polypyridyl Ligands.
    Mallepally RR; Putta VR; Chintakuntla N; Vuradi RK; Kotha LR; Sirasani S
    J Fluoresc; 2016 May; 26(3):1101-13. PubMed ID: 27067208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel C,N-Cyclometalated Benzimidazole Ruthenium(II) and Iridium(III) Complexes as Antitumor and Antiangiogenic Agents: A Structure-Activity Relationship Study.
    Yellol J; Pérez SA; Buceta A; Yellol G; Donaire A; Szumlas P; Bednarski PJ; Makhloufi G; Janiak C; Espinosa A; Ruiz J
    J Med Chem; 2015 Sep; 58(18):7310-27. PubMed ID: 26313136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insights into the binding of half-sandwich phosphino Ir(III) and Ru(II) complexes to deoxyribonucleic acid, albumin and apo-transferrin: Experimental and theoretical investigation.
    Kozieł S; Wojtala D; Szmitka M; Kędzierski P; Bieńko D; Komarnicka UK
    Spectrochim Acta A Mol Biomol Spectrosc; 2024 Jan; 304():123289. PubMed ID: 37651843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel half-sandwich iridium(iii) imino-pyridyl complexes showing remarkable in vitro anticancer activity.
    Li J; Guo L; Tian Z; Tian M; Zhang S; Xu K; Qian Y; Liu Z
    Dalton Trans; 2017 Nov; 46(44):15520-15534. PubMed ID: 29090698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis, and evaluation of fluorine and Naphthyridine-Based half-sandwich organoiridium/ruthenium complexes with bioimaging and anticancer activity.
    Li J; Tian Z; Ge X; Xu Z; Feng Y; Liu Z
    Eur J Med Chem; 2019 Feb; 163():830-839. PubMed ID: 30579123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biological Potential of Halfsandwich Ruthenium(II) and Iridium (III) Complexes.
    Ludwig G; Mojić M; Bulatović M; Mijatović S; Maksimović-Ivanić D; Steinborn D; Kaluđerović GN
    Anticancer Agents Med Chem; 2016; 16(11):1455-1460. PubMed ID: 26510901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Half-sandwich ruthenium(II), rhodium(III) and iridium(III) fluorescent metal complexes containing pyrazoline based ligands: DNA binding, cytotoxicity and antibacterial activities.
    Nongpiur CGL; Verma AK; Singh RK; Ghate MM; Poluri KM; Kaminsky W; Kollipara MR
    J Inorg Biochem; 2023 Jan; 238():112059. PubMed ID: 36345069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.